Hematologic Malignancies
Article
Meta-analysis: Acalabrutinib showed better PFS and OS than other frontline CLL therapies
News
Two new protein biomarkers may serve as prognostic indicators for outcomes in CLL
Study also validated the prognostic value of two previously studied biomarkers.
Clinical Review
Review of Efficacy and Safety Outcomes of Ibrutinib in a Veteran Population with Chronic Lymphocytic Leukemia
What's Your Diagnosis?
Small Bowel Obstruction in a Surgically Naïve Abdomen
Finding the cause of small bowel obstructions can lead to the discovery of important and treatable underlying disease.
News
Levofloxacin prophylaxis improves survival in newly diagnosed myeloma
Levofloxacin looks like a promising addition to therapy, but the researchers cautioned that antibiotic resistance must be considered.
News
‘Forward-Oriented’ Vector Holds Potential for Sickle Cell Cure
Researchers find a new method for gene therapy that shows promise in a cure for treating patients with sickle cell disease.
News
Stem cells gene edited to be HIV resistant treat ALL, but not HIV
Commentary
Genomic Medicine and Genetic Counseling in the Department of Veterans Affairs and Department of Defense
Conference Coverage
SC daratumumab deemed feasible for every multiple myeloma patient
CHICAGO – In the COLUMBA trial, subcutaneous daratumumab proved noninferior to intravenous daratumumab in overall response rate and maximum trough...
Latest News
Another study supports safety of 2-cm margins for thick melanomas
Similar outcomes seen with 4-cm and 2-cm excision margins for melanomas greater than 2 mm.